1. Home
  2. RCKY vs ARCT Comparison

RCKY vs ARCT Comparison

Compare RCKY & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rocky Brands Inc.

RCKY

Rocky Brands Inc.

SELL

Current Price

$45.53

Market Cap

339.2M

ML Signal

SELL

Logo Arcturus Therapeutics Holdings Inc.

ARCT

Arcturus Therapeutics Holdings Inc.

SELL

Current Price

$12.69

Market Cap

369.5M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
RCKY
ARCT
Founded
1932
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Shoe Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
339.2M
369.5M
IPO Year
1996
2019

Fundamental Metrics

Financial Performance
Metric
RCKY
ARCT
Price
$45.53
$12.69
Analyst Decision
Strong Buy
Analyst Count
0
13
Target Price
N/A
★ $23.80
AVG Volume (30 Days)
42.9K
★ 774.6K
Earning Date
10-27-2026
11-09-2026
Dividend Yield
★ 1.51%
N/A
EPS Growth
★ 94.74
20.00
EPS
★ 1.99
N/A
Revenue
★ $270,408,000.00
$82,031,000.00
Revenue This Year
$8.48
N/A
Revenue Next Year
$4.75
$64.21
P/E Ratio
$22.61
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$26.74
$5.50
52 Week High
$53.01
$24.14

Technical Indicators

Market Signals
Indicator
RCKY
ARCT
Relative Strength Index (RSI) 53.46 45.02
Support Level $31.90 $6.53
Resistance Level $48.70 $15.17
Average True Range (ATR) 1.18 1.15
MACD 0.06 -0.28
Stochastic Oscillator 57.50 19.59

Price Performance

Historical Comparison
RCKY
ARCT

About RCKY Rocky Brands Inc.

Rocky Brands Inc is a designer, manufacturer, and marketer of premium footwear and apparel under brands such as Muck, XTRATUF, Rocky, Durango, Georgia Boot, Lehigh, Ranger, and the licensed brand Michelin. The company operates through three segments, with the wholesale segment generating the majority of revenue through sales of footwear and accessories to sporting goods stores, outdoor specialty stores, online retailers, marine stores, independent retailers, mass merchants, retail uniform stores, and specialty safety shoe stores. The retail segment focuses on direct-to-consumer sales through e-commerce platforms and company-operated stores, while the contract manufacturing segment includes sales to the U.S. military, private label production, and sourcing arrangements for customers.

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.

Share on Social Networks: